NCT Number: NCT04812366
Phase: Phase 2
Trial Summary: The objective of this study is to see if providing an appropriate therapy based on the genomic testing of prostate tumour tissue will result in an improved clinical response. Each participant will be – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of British Columbia
Acronym: GUNS
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives